Foot and Mouth Disease Vaccine Market Size, Share, Growth, Trends, and Global Industry Analysis: Size, Share, Growth, Trends, and Global Industry Analysis By Type (Aluminum Hydroxide and Saponin Vaccines , Oil-based Vaccines), By Animal (Cattle, Sheep and Goat, Swine / Pig and Others), By Distribution Channel (Veterinary Clinics, Government Institutions and Others), and Region Forecast 2019 to 2030.

Foot and Mouth Disease Vaccine Market was valued at US$ 2,893.1 million in 2023 and grew at 8.9% CAGR during the forecast years (2024-2030). The Foot and Mouth Disease (FMD) vaccine is a biologic product intended to immunise livestock against the extremely contagious viral virus that affects animals with cloven hooves, including cattle, sheep, goats, and pigs. Due to reduced cattle output, animal deaths, and trade restrictions, FMD causes significant economic losses. By fostering immunity, stopping the virus's propagation, and safeguarding the wellbeing of livestock, the vaccine aids in the containment of outbreaks. The recurrent outbreaks of FMD globally are pushing governments and farmers to adopt vaccination programs to protect livestock. According to the World Organisation for Animal Health (OIE), more than 100 countries report FMD outbreaks annually, especially in Africa, Asia, and parts of South America.

Furthermore, many governments, particularly in developing nations, actively support vaccination programs. For instance, the Indian government has launched the National Animal Disease Control Programme (NADCP), which aims to vaccinate 500 million cattle against FMD by 2025.

Whereas, FMD vaccination logistics and the cold chain can be very difficult in many nations, particularly in low-income areas. It is challenging to maintain the cold chain from production to isolated rural areas, and many vaccines have special storage requirements.

However, potential for more robust, long-lasting protection is provided by recent scientific discoveries and technical developments in the manufacture of vaccinations, such as DNA and synthetic vaccines. Businesses that invest in these developments stand to gain a lot from the market.

Foot and Mouth Disease Vaccine Market Key Developments:

• In 2023, MSD Animal Health launched its FMD synthetic vaccine in collaboration with The Pirbright Institute, a leading global animal health research center. This vaccine can be produced without live FMD virus, reducing biosecurity risks during production.
• In 2022, Boehringer Ingelheim, a major player in the animal health sector, acquired GlobalVet to strengthen its animal vaccine portfolio, including FMD vaccines, especially in emerging markets where FMD is endemic.
• In 2021, Zoetis, a leading animal health company, launched its updated FMD vaccine, which uses advanced antigen technology to cover more strains of the FMD virus. This has helped improve the vaccine’s efficacy in regions facing frequent FMD outbreaks.